David James Peter Henderson

Title: David James Peter Henderson: Innovator in Prostate Cancer Diagnostics

Introduction

David James Peter Henderson is a notable inventor based in Newton Stewart, GB. He has made significant contributions to the field of medical diagnostics, particularly in relation to prostate cancer. With a total of 3 patents, Henderson's work focuses on innovative methods for diagnosing and monitoring prostate cancer.

Latest Patents

Henderson's latest patents include groundbreaking inventions such as the use of phosphodiesterase 9A (PDE9A) as a marker for prostate cancer. This invention relates to the application of PDE9A for diagnosing, detecting, monitoring, or prognosticating prostate cancer and its progression. Additionally, he has developed methods and immunoassays for identifying individuals eligible for prostate cancer therapy. Another significant patent involves phosphodiesterase 4D7 (PDE4D7) as a marker for malignant, hormone-sensitive prostate cancer. This invention aims to improve diagnostic accuracy and treatment strategies for patients suffering from this condition.

Career Highlights

Throughout his career, Henderson has worked with prominent organizations such as Koninklijke Philips Corporation N.V. and the University of Glasgow. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to advancements in medical technology.

Collaborations

Some of Henderson's notable coworkers include Ralf Hoffmann and Miles Douglas Houslay. Their collaborative efforts have further enhanced the impact of his inventions in the medical community.

Conclusion

David James Peter Henderson is a distinguished inventor whose work in prostate cancer diagnostics has the potential to transform patient care. His innovative patents and collaborations reflect his commitment to advancing medical science and improving health outcomes for individuals affected by prostate cancer.